Trading involves risk
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Trading involves risk
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
English (International)
Inspire Medical Systems Inc
Closed
SectorHealthcare
149.37 -4.05
Overview
Share price change
24h
Min
148.63
Max
154.92
Income | -32M 3M |
|---|---|
Sales | -38M 201M |
P/E Sector Avg | 71.434 56.602 |
EPS | 0.099 |
Profit margin | 1.486 |
Employees | 1,246 |
EBITDA | -58M -1.5M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +39.46% upside |
Next Earnings | 5 Aug 2025 |
|---|
Market Cap | -142M 4.6B |
|---|---|
Previous open | 153.42 |
Previous close | 149.37 |
News Sentiment
By Acuity
80%
20%
364 / 382 Healthcare
Inspire Medical Systems Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Inspire Medical Systems Inc Forecast
Price Target
By TipRanks
39.46% upside
12 Months Forecast
Average 217.31 USD 39.46%
High 270 USD
Low 174 USD
Based on 14 Wall Street analysts offering 12 month price targets forInspire Medical Systems Inc - Dist in the last 3 months.
Sentiment
By Acuity
364 / 382 Healthcare
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
